Alector, Inc.
ALEC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001653087
In the last 90 days, Alector, Inc. insiders filed 0 open-market purchases and 3 sales; 140 institutions reported holding it in 13F filings for Q2 2026, worth $183.4M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Alector, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 136 | 149 | +13 |
| Shares | 70.5M | 74.7M | +4.24M (+6.0%) |
| Value | $98.7M | $221.2M | +$122.5M (+124.1%) |
New holders (25)
Institutions that held Alector, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
Sold out (12)
Institutions that held Alector, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| ADAR1 Capital Management, LLC | 1,723,526 | $2.41M |
| Sio Capital Management, LLC | 845,531 | $1.18M |
| Walleye Capital LLC | 266,204 | $372.7K |
| State of Wyoming | 223,092 | $312.3K |
| Gsa Capital Partners LLP | 150,669 | $211.0K |
| Susquehanna Fundamental Investments, LLC | 70,778 | $99.1K |
| Algert Global LLC | 44,460 | $62.2K |
| State Board of Administration of Florida Retirement System | 25,570 | $35.8K |
| Shell Asset Management Co | 13,887 | $19.0K |
| US Bancorp | 12,427 | $17.4K |
| Raymond James Financial Inc | 1,479 | $2.07K |
| Skopos Labs, Inc. | 601 | $842 |